Checkmate8HW Archives

First results of the Checkmate 8HW study show first-line dual immunotherapy combination improves outcomes versus standard chemotherapy in metastatic colorectal cancer subtype

Checkmate 8HW is the first phase III study to assess first-line nivolumab plus ipilimumab in patients with unresectable microsatellite instability-high/mismatch…